Hologic Long Term Investments vs Net Debt Analysis
HOLX Stock | USD 74.74 0.12 0.16% |
Hologic financial indicator trend analysis is much more than just examining Hologic latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Hologic is a good investment. Please check the relationship between Hologic Long Term Investments and its Net Debt accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.
Long Term Investments vs Net Debt
Long Term Investments vs Net Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Hologic Long Term Investments account and Net Debt. At this time, the significance of the direction appears to have weak relationship.
The correlation between Hologic's Long Term Investments and Net Debt is 0.3. Overlapping area represents the amount of variation of Long Term Investments that can explain the historical movement of Net Debt in the same time period over historical financial statements of Hologic, assuming nothing else is changed. The correlation between historical values of Hologic's Long Term Investments and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Investments of Hologic are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Long Term Investments i.e., Hologic's Long Term Investments and Net Debt go up and down completely randomly.
Correlation Coefficient | 0.3 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Long Term Investments
Long Term Investments is an item on the asset side of Hologic balance sheet that represents investments Hologic intends to hold for over a year. Hologic long term investments may include different instruments such as stocks, bonds, real estate and cash.Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Most indicators from Hologic's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Hologic current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.At this time, Hologic's Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 0.11 in 2024, whereas Tax Provision is likely to drop slightly above 138.5 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 95.1M | 111.1M | 127.8M | 73.1M | Depreciation And Amortization | 464.5M | 323.4M | 371.9M | 390.5M |
Hologic fundamental ratios Correlations
Click cells to compare fundamentals
Hologic Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Hologic fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 7.2B | 8.9B | 9.1B | 9.1B | 10.5B | 11.0B | |
Short Long Term Debt Total | 3.0B | 3.0B | 2.8B | 2.8B | 3.2B | 1.8B | |
Total Current Liabilities | 1.2B | 1.3B | 937.7M | 1.2B | 1.4B | 1.5B | |
Total Stockholder Equity | 2.7B | 4.2B | 4.9B | 5.0B | 5.8B | 6.1B | |
Property Plant And Equipment Net | 491.5M | 564.7M | 481.6M | 517M | 594.6M | 624.3M | |
Net Debt | 2.3B | 1.9B | 483.9M | 95.7M | 110.1M | 104.6M | |
Retained Earnings | (1.6B) | 298.3M | 1.6B | 2.1B | 1.9B | 1.9B | |
Cash | 701M | 1.2B | 2.3B | 2.7B | 3.1B | 3.3B | |
Non Current Assets Total | 5.0B | 5.8B | 5.2B | 5.0B | 5.7B | 3.0B | |
Cash And Short Term Investments | 701M | 1.2B | 2.3B | 2.7B | 3.1B | 3.3B | |
Net Receivables | 1.0B | 942.7M | 617.6M | 625.6M | 719.4M | 755.4M | |
Common Stock Shares Outstanding | 264.6M | 259.7M | 253.8M | 248.8M | 286.2M | 167.9M | |
Liabilities And Stockholders Equity | 7.2B | 8.9B | 9.1B | 9.1B | 10.5B | 11.0B | |
Non Current Liabilities Total | 3.2B | 3.4B | 3.3B | 2.9B | 3.4B | 2.0B | |
Inventory | 395.1M | 501.2M | 623.7M | 617.6M | 710.2M | 745.8M | |
Other Stockholder Equity | 4.3B | 4.0B | 3.5B | 3.1B | 3.6B | 2.5B | |
Total Liab | 4.5B | 4.7B | 4.2B | 4.1B | 4.7B | 2.4B | |
Total Current Assets | 2.2B | 3.2B | 3.9B | 4.2B | 4.8B | 5.1B | |
Non Currrent Assets Other | 489.7M | 214.3M | 188.8M | 267.9M | 308.1M | 323.5M | |
Other Current Assets | 97.3M | 554.5M | 281.2M | 206.9M | 237.9M | 249.8M | |
Other Current Liab | 549.5M | 599.9M | 538.5M | 8.2M | 9.4M | 9.0M | |
Accounts Payable | 178.8M | 215.9M | 197.7M | 712.9M | 819.8M | 860.8M | |
Short Term Debt | 324.9M | 313M | 15M | 287M | 330.1M | 177.8M | |
Property Plant And Equipment Gross | 572.2M | 1.3B | 1.3B | 1.3B | 1.5B | 1.6B | |
Accumulated Other Comprehensive Income | (49.7M) | (59.1M) | (238.2M) | (147.6M) | (132.8M) | (126.2M) | |
Short Term Investments | 6M | 100K | 31.9M | 16.2M | 14.6M | 10.7M | |
Other Assets | 424.5M | 245.7M | 210.5M | 179M | 205.9M | 216.1M | |
Long Term Debt | 2.7B | 2.7B | 2.8B | 2.5B | 2.9B | 2.2B | |
Treasury Stock | (926M) | (1.6B) | (2.0B) | (2.5B) | (2.3B) | (2.2B) | |
Intangible Assets | 1.3B | 1.7B | 1.3B | 888.6M | 1.0B | 1.8B | |
Property Plant Equipment | 491.5M | 564.7M | 481.6M | 579.7M | 666.7M | 337.5M | |
Current Deferred Revenue | 186.1M | 198M | 186.5M | 199.2M | 229.1M | 128.0M | |
Good Will | 2.7B | 3.3B | 3.2B | 3.3B | 3.8B | 2.3B | |
Other Liab | 429.3M | 662.3M | 448.9M | 321.5M | 369.7M | 441.1M | |
Net Tangible Assets | (1.3B) | (722.2M) | 359.1M | 847M | 974.1M | 1.0B | |
Long Term Debt Total | 2.8B | 2.7B | 2.7B | 2.8B | 3.2B | 3.2B | |
Capital Surpluse | 5.8B | 5.9B | 6.0B | 6.0B | 6.9B | 6.1B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Hologic Stock analysis
When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |
Is Hologic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hologic. If investors know Hologic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hologic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.17) | Earnings Share 1.94 | Revenue Per Share 16.391 | Quarterly Revenue Growth (0.01) | Return On Assets 0.0622 |
The market value of Hologic is measured differently than its book value, which is the value of Hologic that is recorded on the company's balance sheet. Investors also form their own opinion of Hologic's value that differs from its market value or its book value, called intrinsic value, which is Hologic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hologic's market value can be influenced by many factors that don't directly affect Hologic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hologic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hologic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hologic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.